» Articles » PMID: 35464749

Laboratory Medicine in Pandemic of COVID-19

Overview
Specialty Biochemistry
Date 2022 Apr 25
PMID 35464749
Authors
Affiliations
Soon will be listed here.
Abstract

After the outbreak in China in the year 2019, severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) quickly spread around the world causing a protracted pandemic. Approximately one-third of infections appear to be asymptomatic. Symptomatic disease is characterized primarily by symptoms of respiratory tract infection of varying severity. But Coronavirus Disease 2019 (COVID-19) is much more than an acute respiratory disease because SARS-CoV-2 affects many organs inducing a vast number of symptoms such as cardiovascular, neurological, gastrointestinal, dermatological, with numerous complications. Short and long-term effects of infection, severe ones, and especially mild forms of the disease which affect a huge number of patients need to be further investigated. Laboratory medicine has a crucial role in early diagnosis of the disease, recognition of the patients who need hospital care, and close monitoring of hospitalized patients to timely identify associated clinical complications as well as follow-up of patients with long-term COVID-19.

References
1.
Dinnes J, Deeks J, Berhane S, Taylor M, Adriano A, Davenport C . Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2021; 3:CD013705. PMC: 8078597. DOI: 10.1002/14651858.CD013705.pub2. View

2.
Shah A, Frost J, Aaron L, Donovan K, Drakesmith H . Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19. Crit Care. 2020; 24(1):320. PMC: 7280775. DOI: 10.1186/s13054-020-03051-w. View

3.
Palladino M . Complete blood count alterations in COVID-19 patients: A narrative review. Biochem Med (Zagreb). 2021; 31(3):030501. PMC: 8495616. DOI: 10.11613/BM.2021.030501. View

4.
Soy M, Keser G, Atagunduz P, Tabak F, Atagunduz I, Kayhan S . Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol. 2020; 39(7):2085-2094. PMC: 7260446. DOI: 10.1007/s10067-020-05190-5. View

5.
Wang F, Kream R, Stefano G . Long-Term Respiratory and Neurological Sequelae of COVID-19. Med Sci Monit. 2020; 26:e928996. PMC: 7643287. DOI: 10.12659/MSM.928996. View